EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.375
https://www.valueinhealthjournal.com/article/S1098-3015(22)00576-9/fulltext
Title :
EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00576-9&doi=10.1016/j.jval.2022.04.375
First page :
Section Title :
Open access? :
No
Section Order :
10327